DE167317C - - Google Patents
Info
- Publication number
- DE167317C DE167317C DENDAT167317D DE167317DA DE167317C DE 167317 C DE167317 C DE 167317C DE NDAT167317 D DENDAT167317 D DE NDAT167317D DE 167317D A DE167317D A DE 167317DA DE 167317 C DE167317 C DE 167317C
- Authority
- DE
- Germany
- Prior art keywords
- base
- adrenal
- boric acid
- water
- solutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001919 adrenal effect Effects 0.000 claims description 19
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 13
- 239000004327 boric acid Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000002585 base Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 15
- 235000010338 boric acid Nutrition 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- -1 boric acid compound Chemical class 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical compound CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005340 analytical number Methods 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE167317C true DE167317C (enExample) |
Family
ID=432640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT167317D Active DE167317C (enExample) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE167317C (enExample) |
-
0
- DE DENDAT167317D patent/DE167317C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69000641T2 (de) | Imipramin enthaltende arzneizubereitungen. | |
| DE3124014A1 (de) | Aluminiumibuprofensuspensionen | |
| DE3133443A1 (de) | Mikrokristallines cisplatin | |
| DE2422767B2 (de) | Verfahren zur Herstellung einer Jodophor-Zusammensetzung | |
| EP1018337A2 (de) | Chlorhexidin-Formulierungen, neue Chlorhexidinsalze, sie enthaltende Lösungen und deren Verwendung | |
| DE3238800A1 (de) | Mit (gamma)-cyclodextrin gebildete einschlusskomplexe von steroidverbindungen, verfahren zu ihrer herstellung und diese einschlusskomplexe enthaltende arzneimittelpraeparate | |
| DE3786965T2 (de) | Feste Jodophorzusammensetzung. | |
| DE167317C (enExample) | ||
| EP0124774A1 (de) | Polyvinylpyrrolydon-Jod-Wundpulver mit synergistisch wirkender Pudergrundlage | |
| DE1467749A1 (de) | Verfahren zur Herstellung von stabilen Tetracyclinpraeparaten | |
| DE3337506C2 (enExample) | ||
| CH635816A5 (en) | Process for preparing a novel, solid cholinesalicylate complex | |
| DE102005060690B4 (de) | Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen | |
| DE165984C (enExample) | ||
| DE854952C (de) | Verfahren zur Herstellung von komplexen Aureomycin-Verbindungen | |
| DE255030C (enExample) | ||
| DE2820992A1 (de) | Arzneimittel auf nitroimidazol-basis | |
| DE413381C (de) | Verfahren zur Herstellung von in Wasser leicht loeslichen, bei Abwesenheit von Feuchtigkeit dauernd haltbaren Derivaten der Arsenobenzol- und Stibinobenzolreihe, sowie der ent-sprechenden gemischten Arsen-Antimon- und Arsen-Wismutverbindungen | |
| DE3044736A1 (de) | Antitumor-mittel, verfahren zu deren herstellung und dosierungsformen | |
| DE955060C (de) | Verfahren zur Herstellung von Penicillinsalzen | |
| DE105866C (enExample) | ||
| DE289001C (enExample) | ||
| DE701320C (de) | Verfahren zur Herstellung von Jodverbindungen der Glykochol- und/oder Taurocholsaeure | |
| Gamgee et al. | Ueber Protagon | |
| DE275092C (enExample) |